Dr. Lindsay S. Ackerman, MD
Dermatology (Dermatology Physician)
1331 N 7th St Ste 250
Phoenix, AZ 85006
Who else practices at this address →
Maricopa County includes primary care (13% of residents) and dental (0% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Arizona College of Medicine (2003)
- Years since graduation
- 23
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 861
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2003Medical school: University of Arizona College of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
AZ license 37754
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Banner - University Medical Center Phoenix Phoenix, AZ
Medical groups
- Southwest Skin Specialists LLC (52 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 861
- Services billed
- 6,636
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 1,907 | 349 |
| Established patient office or other outpatient visit, 20-29 minutes | 1,075 | 742 |
| Destruction of precancer skin growth, 1 growth | 770 | 512 |
| Biopsy of related skin growth, first growth | 549 | 410 |
| Established patient office or other outpatient visit, 30-39 minutes | 381 | 214 |
| Destruction of skin growth, 1-14 growths | 266 | 204 |
| Biopsy of related skin growth, each additional growth | 231 | 144 |
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 97 | 12 |
| Established patient office or other outpatient visit, 10-19 minutes | 94 | 81 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 75 | 64 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 21 companies reported 435 payments worth $360,526 in total to this clinician.
| AbbVie Inc. | $119,051 |
|---|---|
| Lilly USA, LLC | $65,122 |
| UCB, Inc. | $39,479 |
| Incyte Corporation | $24,143 |
| Leo Pharma Inc. | $17,401 |
| Galderma Laboratories, L.P. | $17,032 |
| Janssen Biotech, Inc. | $16,744 |
| E.r. Squibb & Sons, L.l.c. | $16,056 |
| Compensation for services other than consulting (speaking, faculty) | $244,754 |
|---|---|
| Consulting Fee | $84,900 |
| Travel and Lodging | $22,513 |
| Food and Beverage | $8,349 |
| Education | $9.65 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Eli Lilly and Company Jan 13, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $10,400 |
| Incyte Corporation Dec 23, 2025 | Consulting Fee Opzelura · Dermatology | $7,335 |
| UCB, Inc. Mar 26, 2025 | Compensation for services other than consulting (speaking, faculty) Bimzelx · Immunology | $6,972 |
| AbbVie Inc. Feb 26, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $6,125 |
| AbbVie Inc. May 15, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $6,125 |
| AbbVie Inc. May 15, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $6,125 |
| AbbVie Inc. Jul 9, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $6,125 |
| Janssen Biotech, Inc. Mar 29, 2025 | Compensation for services other than consulting (speaking, faculty) TREMFYA · Immunology | $5,950 |
| Lilly USA, LLC May 8, 2025 | Consulting Fee EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $5,600 |
| Lilly USA, LLC Jun 12, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $5,600 |
All 177 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Incyte Corporation Dec 23, 2025 | Consulting Fee Opzelura · Dermatology | $7,335 |
| Incyte Corporation Dec 23, 2025 | Consulting Fee Opzelura · Dermatology | $4,890 |
| Novartis Pharmaceuticals Corporation Dec 19, 2025 | Consulting Fee COSENTYX · Dermatology | $2,700 |
| Leo Pharma Inc. Dec 18, 2025 | Consulting Fee ADBRY; ANZUPGO · DERMATOLOGY | $1,900 |
| UCB, Inc. Dec 11, 2025 | Consulting Fee Bimzelx · Immunology | $150 |
| Incyte Corporation Dec 4, 2025 | Travel and Lodging Opzelura · Dermatology · travel to Phoenix, AZ | $66.00 |
| Incyte Corporation Dec 3, 2025 | Travel and Lodging Opzelura · Dermatology · travel to Philadelphia, PA | $519 |
| Incyte Corporation Dec 3, 2025 | Travel and Lodging Opzelura · Dermatology · travel to Wilmington, DE | $439 |
| Incyte Corporation Dec 3, 2025 | Travel and Lodging Opzelura · Dermatology · travel to Wilmington, DE | $50.94 |
| AbbVie Inc. Dec 1, 2025 | Consulting Fee | $4,375 |
| Galderma Laboratories, L.P. Nov 21, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $2,250 |
| UCB, Inc. Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) Bimzelx · Immunology | $4,500 |
| Kyowa Kirin, Inc. Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) POTELIGEO · MONOCLONAL ANTIBODY | $800 |
| AbbVie Inc. Nov 14, 2025 | Consulting Fee | $875 |
| Leo Pharma Inc. Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) ANZUPGO · DERMATOLOGY | $3,420 |
| Lilly USA, LLC Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,600 |
| Leo Pharma Inc. Nov 6, 2025 | Compensation for services other than consulting (speaking, faculty) ANZUPGO · DERMATOLOGY | $5,320 |
| Leo Pharma Inc. Nov 6, 2025 | Consulting Fee ANZUPGO · DERMATOLOGY | $1,900 |
| AbbVie Inc. Nov 6, 2025 | Consulting Fee RINVOQ · IMMUNOLOGY | $875 |
| Pfizer Inc. Nov 5, 2025 | Compensation for services other than consulting (speaking, faculty) CIBINQO · Inflammation & Immunology | $4,125 |
| AbbVie Inc. Oct 31, 2025 | Consulting Fee | $5,250 |
| Lilly USA, LLC Oct 31, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Oct 31, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $1,200 |
| E.r. Squibb & Sons, L.l.c. Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) Sotyktu · Immunology | $4,113 |
| AbbVie Inc. Oct 29, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $4,375 |
| UCB, Inc. Oct 29, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Scottsdale, AZ · in-kind | $396 |
| Lilly USA, LLC Oct 29, 2025 | Travel and Lodging travel to AVONDALE, AZ · in-kind | $212 |
| Sun Pharmaceutical Industries Inc. Oct 22, 2025 | Consulting Fee Unloxcyt · Oncology | $3,000 |
| Sun Pharmaceutical Industries Inc. Oct 22, 2025 | Travel and Lodging Unloxcyt · Oncology · travel to Las Vegas, NV | $229 |
| Sun Pharmaceutical Industries Inc. Oct 22, 2025 | Travel and Lodging Unloxcyt · Oncology · travel to Las Vegas, NV | $38.09 |
| E.r. Squibb & Sons, L.l.c. Oct 17, 2025 | Compensation for services other than consulting (speaking, faculty) Sotyktu · Immunology | $2,350 |
| Leo Pharma Inc. Oct 16, 2025 | Consulting Fee ANZUPGO · DERMATOLOGY | $1,200 |
| AbbVie Inc. Oct 16, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to SCOTTSDALE, AZ · in-kind | $660 |
| UCB, Inc. Oct 16, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Scottsdale, AZ · in-kind | $15.00 |
| AbbVie Inc. Oct 14, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $2,625 |
| AbbVie Inc. Oct 6, 2025 | Education RINVOQ · IMMUNOLOGY · in-kind | $9.65 |
| Lilly USA, LLC Oct 3, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Oct 3, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $2,000 |
| AbbVie Inc. Oct 2, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $2,625 |
| Lilly USA, LLC Oct 1, 2025 | Travel and Lodging travel to GILBERT, AZ · in-kind | $458 |
| UCB, Inc. Sep 30, 2025 | Compensation for services other than consulting (speaking, faculty) Bimzelx · Immunology | $4,500 |
| Lilly USA, LLC Sep 22, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Sep 22, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $2,000 |
| Lilly USA, LLC Sep 17, 2025 | Travel and Lodging travel to SURPRISE, AZ · in-kind | $318 |
| Galderma Laboratories, L.P. Sep 15, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $600 |
| Galderma Laboratories, L.P. Sep 5, 2025 | Consulting Fee NEMLUVIO · DERMATITIS | $2,500 |
| Genzyme Corporation Aug 20, 2025 | Travel and Lodging travel to Chicago, IL | $48.00 |
| Genzyme Corporation Aug 13, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $854 |
| Incyte Corporation Aug 8, 2025 | Consulting Fee OPZELURA · Dermatology | $4,875 |
| Incyte Corporation Aug 8, 2025 | Consulting Fee OPZELURA · Dermatology | $4,500 |
| Lilly USA, LLC Aug 8, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Aug 8, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $1,200 |
| AbbVie Inc. Aug 5, 2025 | Consulting Fee SKYRIZI · IMMUNOLOGY | $219 |
| AbbVie Inc. Jul 30, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to CINCINNATI, OH · in-kind | $33.00 |
| AbbVie Inc. Jul 30, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to CINCINNATI, OH · in-kind | $31.96 |
| UCB, Inc. Jul 29, 2025 | Compensation for services other than consulting (speaking, faculty) Bimzelx · Immunology | $4,500 |
| Janssen Biotech, Inc. Jul 26, 2025 | Compensation for services other than consulting (speaking, faculty) TREMFYA · Immunology | $1,275 |
| AbbVie Inc. Jul 21, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $2,625 |
| AbbVie Inc. Jul 18, 2025 | Consulting Fee SKYRIZI · IMMUNOLOGY | $2,479 |
| UCB, Inc. Jul 17, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Chandler, AZ · in-kind | $474 |
| Genzyme Corporation Jul 16, 2025 | Consulting Fee | $3,548 |
| UCB, Inc. Jul 16, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Chandler, AZ · in-kind | $15.00 |
| Genzyme Corporation Jul 10, 2025 | Travel and Lodging travel to Chicago, IL · in-kind | $401 |
| Genzyme Corporation Jul 10, 2025 | Travel and Lodging travel to Chicago, IL · in-kind | $281 |
| Genzyme Corporation Jul 10, 2025 | Travel and Lodging travel to Chicago, IL · in-kind | $265 |
| AbbVie Inc. Jul 9, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $6,125 |
| Galderma Laboratories, L.P. Jul 7, 2025 | Consulting Fee NEMLUVIO · DERMATITIS | $2,500 |
| AbbVie Inc. Jul 2, 2025 | Consulting Fee | $1,021 |
| Incyte Corporation Jun 26, 2025 | Travel and Lodging OPZELURA · Dermatology · travel to Phoenix, AZ | $66.00 |
| Incyte Corporation Jun 25, 2025 | Travel and Lodging OPZELURA · Dermatology · travel to Philadelphia, PA | $621 |
| Incyte Corporation Jun 25, 2025 | Travel and Lodging OPZELURA · Dermatology · travel to Wilmington, DE | $369 |
| AbbVie Inc. Jun 20, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $2,625 |
| AbbVie Inc. Jun 19, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to CINCINNATI, OH · in-kind | $323 |
| AbbVie Inc. Jun 19, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to CINCINNATI, OH · in-kind | $165 |
| Lilly USA, LLC Jun 16, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,600 |
| AbbVie Inc. Jun 13, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $4,375 |
| AbbVie Inc. Jun 13, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to BATON ROUGE, LA · in-kind | $90.00 |
| Lilly USA, LLC Jun 12, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $5,600 |
| Lilly USA, LLC Jun 11, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $800 |
| Galderma Laboratories, L.P. Jun 6, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $3,600 |
| Janssen Biotech, Inc. Jun 6, 2025 | Compensation for services other than consulting (speaking, faculty) TREMFYA · Immunology | $50.00 |
| Leo Pharma Inc. Jun 5, 2025 | Consulting Fee ADBRY · DERMATOLOGY | $1,302 |
| Pfizer Inc. Jun 5, 2025 | Consulting Fee CIBINQO · Inflammation & Immunology | $750 |
| Lilly USA, LLC Jun 5, 2025 | Travel and Lodging travel to IRVING, IL · in-kind | $411 |
| AbbVie Inc. Jun 2, 2025 | Consulting Fee SKYRIZI · IMMUNOLOGY | $438 |
| AbbVie Inc. May 28, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to PHOENIX, AZ · in-kind | $582 |
| Galderma Laboratories, L.P. May 21, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $2,250 |
| UCB, Inc. May 20, 2025 | Compensation for services other than consulting (speaking, faculty) Bimzelx · Immunology | $4,500 |
| AbbVie Inc. May 15, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $6,125 |
| AbbVie Inc. May 15, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $6,125 |
| AbbVie Inc. May 15, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $4,375 |
| AbbVie Inc. May 15, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $4,375 |
| Lilly USA, LLC May 8, 2025 | Consulting Fee EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $5,600 |
| Lilly USA, LLC May 8, 2025 | Consulting Fee EBGLYSS · Immunology | $2,800 |
| AbbVie Inc. May 5, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $2,625 |
| AbbVie Inc. Apr 29, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $2,625 |
| AbbVie Inc. Apr 29, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to BATON ROUGE, LA · in-kind | $1,831 |
| AbbVie Inc. Apr 29, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to BATON ROUGE, LA · in-kind | $529 |
| AbbVie Inc. Apr 29, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to BATON ROUGE, LA · in-kind | $324 |
| AbbVie Inc. Apr 29, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to CINCINNATI, OH · in-kind | $165 |
| AbbVie Inc. Apr 29, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to BATON ROUGE, LA · in-kind | $6.00 |
| Novartis Pharmaceuticals Corporation Apr 24, 2025 | Consulting Fee COSENTYX · Dermatology | $1,800 |
| Amgen Inc. Apr 24, 2025 | Compensation for services other than consulting (speaking, faculty) Otezla · Inflammation | $1,500 |
| Lilly USA, LLC Apr 24, 2025 | Travel and Lodging travel to PHOENIX, AZ · in-kind | $233 |
| Lilly USA, LLC Apr 24, 2025 | Travel and Lodging travel to PHOENIX, CO · in-kind | $158 |
| AbbVie Inc. Apr 22, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to BATON ROUGE, LA · in-kind | $329 |
| Janssen Biotech, Inc. Apr 19, 2025 | Compensation for services other than consulting (speaking, faculty) TREMFYA · Immunology | $3,825 |
| Janssen Biotech, Inc. Apr 19, 2025 | Compensation for services other than consulting (speaking, faculty) TREMFYA · Immunology | $850 |
| Lilly USA, LLC Apr 15, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Apr 15, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $1,200 |
| Janssen Biotech, Inc. Apr 12, 2025 | Compensation for services other than consulting (speaking, faculty) TREMFYA · Immunology | $1,700 |
| UCB, Inc. Apr 8, 2025 | Compensation for services other than consulting (speaking, faculty) Bimzelx · Immunology | $4,150 |
| Lilly USA, LLC Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $1,200 |
| Janssen Biotech, Inc. Apr 7, 2025 | Travel and Lodging TREMFYA · Immunology · travel to NEW ORLEANS, LA | $66.00 |
| Janssen Biotech, Inc. Apr 7, 2025 | Travel and Lodging TREMFYA · Immunology · travel to NEW ORLEANS, LA | $41.00 |
| Leo Pharma Inc. Apr 3, 2025 | Consulting Fee ANZUPGO; ADBRY · DERMATOLOGY | $1,900 |
| Lilly USA, LLC Apr 2, 2025 | Travel and Lodging travel to SURPRISE, AZ · in-kind | $318 |
| Janssen Biotech, Inc. Mar 29, 2025 | Compensation for services other than consulting (speaking, faculty) TREMFYA · Immunology | $5,950 |
| Janssen Biotech, Inc. Mar 28, 2025 | Travel and Lodging TREMFYA · Immunology · travel to NEW ORLEANS, LA · in-kind | $462 |
| Janssen Biotech, Inc. Mar 28, 2025 | Travel and Lodging TREMFYA · Immunology · travel to NEW ORLEANS, LA · in-kind | $414 |
| Janssen Biotech, Inc. Mar 28, 2025 | Travel and Lodging TREMFYA · Immunology · travel to NEW ORLEANS, LA · in-kind | $217 |
| UCB, Inc. Mar 26, 2025 | Compensation for services other than consulting (speaking, faculty) Bimzelx · Immunology | $6,972 |
| Lilly USA, LLC Mar 25, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Mar 25, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $2,000 |
| Lilly USA, LLC Mar 24, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Mar 24, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $1,200 |
| AbbVie Inc. Mar 24, 2025 | Consulting Fee SKYRIZI · IMMUNOLOGY | $656 |
| Janssen Biotech, Inc. Mar 22, 2025 | Compensation for services other than consulting (speaking, faculty) TREMFYA · Immunology | $1,650 |
| Lilly USA, LLC Mar 20, 2025 | Travel and Lodging travel to GILBERT, AZ · in-kind | $572 |
| AbbVie Inc. Mar 19, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $2,625 |
| Lilly USA, LLC Mar 19, 2025 | Travel and Lodging travel to SURPRISE, AZ · in-kind | $318 |
| AbbVie Inc. Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $4,375 |
| AbbVie Inc. Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $2,625 |
| Pfizer Inc. Mar 3, 2025 | Compensation for services other than consulting (speaking, faculty) LITFULO · IMMUNOLOGY | $4,275 |
| E.r. Squibb & Sons, L.l.c. Feb 28, 2025 | Compensation for services other than consulting (speaking, faculty) Sotyktu · Immunology | $4,700 |
| AbbVie Inc. Feb 28, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to ZEPHYRHILLS, FL · in-kind | $99.00 |
| AbbVie Inc. Feb 27, 2025 | Consulting Fee SKYRIZI · IMMUNOLOGY | $4,813 |
| AbbVie Inc. Feb 27, 2025 | Consulting Fee SKYRIZI · IMMUNOLOGY | $3,500 |
| AbbVie Inc. Feb 27, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to PHOENIX, AZ · in-kind | $99.00 |
| AbbVie Inc. Feb 26, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $6,125 |
| Kyowa Kirin, Inc. Feb 26, 2025 | Compensation for services other than consulting (speaking, faculty) POTELIGEO · MONOCLONAL ANTIBODY | $4,000 |
| AbbVie Inc. Feb 25, 2025 | Consulting Fee RINVOQ · IMMUNOLOGY | $5,250 |
| AbbVie Inc. Feb 25, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $4,375 |
| AbbVie Inc. Feb 14, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $4,375 |
| AbbVie Inc. Feb 13, 2025 | Travel and Lodging RINVOQ; SKYRIZI · IMMUNOLOGY · travel to LAKE BUENA VISTA, FL · in-kind | $963 |
| AbbVie Inc. Feb 13, 2025 | Travel and Lodging RINVOQ; SKYRIZI · IMMUNOLOGY · travel to LAKE BUENA VISTA, FL · in-kind | $838 |
| UCB, Inc. Feb 11, 2025 | Compensation for services other than consulting (speaking, faculty) Bimzelx · Immunology | $3,750 |
| UCB, Inc. Feb 11, 2025 | Compensation for services other than consulting (speaking, faculty) Bimzelx · Immunology | $3,000 |
| AbbVie Inc. Feb 11, 2025 | Travel and Lodging RINVOQ; SKYRIZI · IMMUNOLOGY · travel to LAKE BUENA VISTA, FL · in-kind | $354 |
| UCB, Inc. Feb 11, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Aurora, CO · in-kind | $66.00 |
| Galderma Laboratories, L.P. Feb 10, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $2,700 |
| E.r. Squibb & Sons, L.l.c. Feb 5, 2025 | Travel and Lodging Sotyktu · Immunology · travel to Phoenix, AZ | $392 |
| AbbVie Inc. Jan 29, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to ZEPHYRHILLS, FL · in-kind | $1,568 |
| AbbVie Inc. Jan 29, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to ZEPHYRHILLS, FL · in-kind | $820 |
| AbbVie Inc. Jan 29, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to ZEPHYRHILLS, FL · in-kind | $644 |
| AbbVie Inc. Jan 29, 2025 | Travel and Lodging SKYRIZI · IMMUNOLOGY · travel to ZEPHYRHILLS, FL · in-kind | $3.87 |
| Lilly USA, LLC Jan 27, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Jan 27, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $1,200 |
| Eli Lilly and Company Jan 22, 2025 | Travel and Lodging travel to DALLAS, TX | $66.00 |
| Lilly USA, LLC Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,600 |
| AbbVie Inc. Jan 16, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to CINCINNATI, OH · in-kind | $854 |
| Eli Lilly and Company Jan 13, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $10,400 |
| Eli Lilly and Company Jan 13, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,800 |
| E.r. Squibb & Sons, L.l.c. Jan 9, 2025 | Compensation for services other than consulting (speaking, faculty) Sotyktu · Immunology | $4,200 |
| Eli Lilly and Company Jan 6, 2025 | Travel and Lodging travel to DALLAS, TX · in-kind | $457 |
| Eli Lilly and Company Jan 6, 2025 | Travel and Lodging travel to DALLAS, TX · in-kind | $162 |
| Eli Lilly and Company Jan 6, 2025 | Travel and Lodging travel to DALLAS, TX · in-kind | $146 |
| Eli Lilly and Company Jan 6, 2025 | Travel and Lodging travel to DALLAS, TX · in-kind | $129 |
| Eli Lilly and Company Jan 6, 2025 | Travel and Lodging travel to DALLAS, TX · in-kind | $108 |
| Eli Lilly and Company Jan 6, 2025 | Travel and Lodging travel to DALLAS, TX · in-kind | $7.58 |
| UCB, Inc. Jan 3, 2025 | Travel and Lodging Bimzelx · Immunology · travel to AURORA, CO · in-kind | $333 |
| UCB, Inc. Jan 3, 2025 | Travel and Lodging Bimzelx · Immunology · travel to AURORA, CO · in-kind | $331 |
| UCB, Inc. Jan 3, 2025 | Travel and Lodging Bimzelx · Immunology · travel to AURORA, CO · in-kind | $178 |
| UCB, Inc. Jan 3, 2025 | Travel and Lodging Bimzelx · Immunology · travel to AURORA, CO · in-kind | $144 |
| UCB, Inc. Jan 3, 2025 | Travel and Lodging Bimzelx · Immunology · travel to AURORA, CO · in-kind | $130 |
| UCB, Inc. Jan 3, 2025 | Travel and Lodging Bimzelx · Immunology · travel to AURORA, CO · in-kind | $58.74 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 42 industry-funded studies in 2025, from 16 companies. The companies reported $1,128,316 in research payments for these studies, mostly to the institutions running them.
- A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
AbbVie Inc. · Active, not recruiting · NCT06468228 - A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
AbbVie Inc. · Active, not recruiting · NCT05889182 - Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight
Eli Lilly and Company · Completed · NCT06588283 - A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa
Incyte Corporation - A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
UCB SA · Completed · NCT04901195 - 24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-lab…
Novartis Pharmaceuticals Corporation - A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Eli Lilly and Company · Completed · NCT06046729 - M20-465 - A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
AbbVie Inc. - TAK-279-PsO-3003 A Phase 3, multi-center, open-label Study To Evaluate The Efficacy, Safety, And Tolerability of TAK-279 in Subjects With Moderate to Severe Plaque Psoriasis
Takeda Pharmaceuticals U.S.A., Inc. - M23-698 - A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (St…
AbbVie Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.